QUICKLINKS AND VIEW OPITONS

EMAIL THE ARTICLE BELOW TO A FRIEND

Email address of your friend:
(For example: myfriend@aol.com)

Your name:
(Example: Lori Jones)

Your email address:
(For example: lorijones@aol.com)

Subject:

Message:
Here is a summary of article I thought you might be interested in. The FDA’s Flawed System of How Antidepressants Get Approved; Negative Trials Ignored Irving Kirsch, PhD from Harvard Medical School tells how antidepressants get approved by the FDA and why it is a flawed system. Only Two Positive Drugs Studies Needed for Approval, While Negative Trials Ignored He notes that drug companies only have to provide two studies showing positive results to get a drug approved regardless of how many trials failed to show any benefit. “The FDA requires two adequately conducted clinical trials showing a significant difference between drug and placebo,” Kirsch writes. “But there is a loophole: There is no limit to the number of trials that can be conducted in search of these two significant trials. “Trials showing negative results simply do not count. “Furthermore, the clinical significance of the findings is not considered. “All that matters is that the results are statistically significant.” Here is the link to the entire article. http://www.fatnews.com/index.php/5921

The FDA’s Flawed System of How Antidepressants Get Approved; Negative Trials Ignored

Irving Kirsch, PhD from Harvard Medical School tells how antidepressants get approved by the FDA and why it is a flawed system.

Only Two Positive Drugs Studies Needed for Approval, While Negative Trials Ignored

He notes that drug companies only have to provide two studies showing positive results to get a drug approved regardless of how many trials failed to show any benefit.

“The FDA requires two adequately conducted clinical trials showing a significant difference between drug and placebo,” Kirsch writes.

“But there is a loophole: There is no limit to the number of trials that can be conducted in search of these two significant trials.

“Trials showing negative results simply do not count.

“Furthermore, the clinical significance of the findings is not considered.

“All that matters is that the results are statistically significant.”

Posted by: Larry Hobbs on Aug 14, 2016 - 10:38 am

© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.

SEARCH THIS SITE

CONTACT US

CATEGORIES

ARCHIVES

ARCHIVE SUMMARY

RSS / XML

QUICKLINKS AND VIEW OPITONS

EMAIL THE ARTICLE BELOW TO A FRIEND

The FDA’s Flawed System of How Antidepressants Get Approved; Negative Trials Ignored